Compare GNLX & ZIONP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GNLX | ZIONP |
|---|---|---|
| Founded | 2001 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 110.4M | N/A |
| IPO Year | 2022 | 2012 |
| Metric | GNLX | ZIONP |
|---|---|---|
| Price | $2.53 | $18.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $17.25 | N/A |
| AVG Volume (30 Days) | ★ 308.3K | 4.7K |
| Earning Date | 05-12-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | 9.47 | ★ 21.41 |
| EPS | N/A | ★ 4.61 |
| Revenue | $8,000.00 | ★ $662,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $3.90 |
| Revenue Growth | N/A | ★ 3.60 |
| 52 Week Low | $2.29 | $17.67 |
| 52 Week High | $8.54 | $22.57 |
| Indicator | GNLX | ZIONP |
|---|---|---|
| Relative Strength Index (RSI) | 45.71 | 46.79 |
| Support Level | $2.34 | $17.67 |
| Resistance Level | $2.90 | $18.45 |
| Average True Range (ATR) | 0.15 | 0.18 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 44.57 | 48.54 |
Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.
Zions Bancorp is a US regional bank with around $90 billion in total assets as of March 31, 2026. Headquartered in Salt Lake City, Utah, Zions' branch network is in the Western and Southwestern United States and includes seven affiliate banks in these markets. The bank has a heavy focus on small and midsize commercial banking.